Efficacy Study of HPV-16/18 Vaccine (GSK 580299) to Prevent HPV-16 and/or -18 Cervical Infection in Young Healthy Women

NCT00689741 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1113

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Papillomavirus

Interventions

BIOLOGICAL: Cervarix
BIOLOGICAL: placebo

Sponsor

GlaxoSmithKline